Delivery Order SPE2DB22D1202-SPE2DB24FVNV3
Award Date
9/16/24
Potential Completion Date
9/17/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,179.73 firm-fixed-price delivery order is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count packages. The contract has an ultimate completion date of April 28, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $60,446.64 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of May 15, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $16,195.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 MG Tablets in 30-count units. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,644.66 firm fixed price delivery order is for the supply of 4,568,142,116 units of telmisartan-HCTZ 40-12.5 mg tablets. The contract has a completion date of May 6, 2025 and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,510.53 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count packages. The contract has an ultimate completion date of July 10, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,017.19 firm-fixed-price delivery order is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit doses of 30s. The contract has an ultimate completion date of October 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,082.60, is a delivery order for Telmisartan-HCTZ 40-12.5 mg tablets, with a completion date of December 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,649.30, is for the delivery of Telmisartan-HCTZ 40-12.5 mg Tablets in 30-count blister packs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 31, 2024. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,966.87, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 10, 2025. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor for...
This federal contract award, valued at $6,920.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Telmisartan-HCTZ 40-12.5 mg tablets, a medication used to treat high blood pressure. The contract is a firm-fixed-price, non-set-aside award with a completion date of May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...